New research suggests many women with the most common form of early-stage breast cancer can safely skip chemotherapy without hurting their chances of beating the disease. Dr. Miguel Albino of Texas Oncology–El Paso Cancer Treatment Center says this study could mean less burden for patients, both financially and in regard to treatment side effects.